Vulvovaginal Candidiasis Clinical Trials

Vulvovaginal candidiasis (VVC), commonly known as a vaginal yeast infection, is a fungal infection caused by an overgrowth of Candida, a yeast that naturally lives in the body. When the normal balance of bacteria and yeast in the vagina is disrupted, Candida can multiply and lead to uncomfortable symptoms.

Most women experience at least one yeast infection during their lifetime, and many improve with standard antifungal medications. However, some develop recurrent vulvovaginal candidiasis (RVVC), experiencing multiple infections each year despite treatment. These recurring episodes can interfere with work, sleep, exercise, intimate relationships, and overall quality of life.

Researchers continue studying recurrent yeast infections to better understand why they return and to evaluate investigational therapies that may offer additional treatment options in the future.

Clinical trials for vulvovaginal candidiasis evaluate investigational therapies designed to better manage or reduce recurrent yeast infections while improving symptom control and patient quality of life.

Research may study recurrence rates, symptom relief, treatment duration, vaginal microbiome balance, and other clinical outcomes associated with recurrent vulvovaginal candidiasis. Some studies focus on women experiencing frequent infections, while others evaluate investigational therapies intended for specific types of Candida infections or women who have not achieved lasting improvement with currently available treatments.

At Equity Medical, every clinical trial is conducted by experienced physicians and clinical research professionals following carefully designed study protocols that prioritize participant safety, ethical research practices, and high-quality scientific data.

Submitting your information does not enroll you in a study. A member of our research team will review your medical history and determine whether a current vulvovaginal candidiasis clinical trial may be a good fit.

For women living with recurrent vulvovaginal candidiasis, the frustration often extends beyond the infection itself. Repeated symptoms, frequent treatment, and uncertainty about when another episode may occur can affect daily comfort and confidence. Clinical research provides an opportunity to contribute to studies focused on improving future care for women experiencing recurring yeast infections.

At Equity Medical, participants receive support from experienced physicians, dedicated study coordinators, and compassionate research professionals who guide them through every stage of the clinical trial process. Our commitment to participant safety, privacy, and scientific excellence helps ensure every study is conducted with the highest standards of care.